Press Releases

Date	Title
October 11, 2022	InVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
October 7, 2022	InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
September 9, 2022	InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment Conference
July 13, 2022	InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel
June 8, 2022	InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery
June 2, 2022	InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
April 14, 2022	InVivo Therapeutics Announces Reverse Stock Split
January 6, 2022	InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright BioConnect Conference